(Q34791688)

English

Efficacy and safety of bifeprunox in patients with an acute exacerbation of schizophrenia: results from a randomized, double-blind, placebo-controlled, multicenter, dose-finding study

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Efficacy and safety of bifeprunox in patients with an acute exacerbation of schizophrenia: results from a randomized, double-blind, placebo-controlled, multicenter, dose-finding study (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

0 references

multicenter clinical trial

0 references

0 references

author name string

Daniel E Casey

1

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Earl E Sands

2

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Jens Heisterberg

3

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Hwa-Ming Yang

4

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

publication date

4 July 2008

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

200

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

317-331

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)

1 reference

https://api.crossref.org/works/10.1007%2FS00213-008-1207-7

21 January 2018

Conventional antipsychotic medications for schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-008-1207-7

21 January 2018

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-008-1207-7

21 January 2018

Prevalence of overweight and obesity in the United States, 1999-2004

1 reference

https://pubmed.ncbi.nlm.nih.gov/18597078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atypical antipsychotics and the burden of disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18597078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Receptor occupancy-based analysis of the contributions of various receptors to antipsychotics-induced weight gain and diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/18597078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antipsychotic drugs: a new risk factor for osteoporosis in young women with schizophrenia?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18597078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improving outcome in schizophrenia: the potential importance of EPS and neuroleptic dysphoria

1 reference

https://pubmed.ncbi.nlm.nih.gov/18597078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18597078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolic syndrome in patients with schizophrenia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18597078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hyperprolactinemia and schizophrenia: mechanisms and clinical aspects

1 reference

https://pubmed.ncbi.nlm.nih.gov/18597078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A meta-analysis of the efficacy of second-generation antipsychotics

1 reference

https://pubmed.ncbi.nlm.nih.gov/18597078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DU-127090 Solvay/H Lundbeck

1 reference

https://pubmed.ncbi.nlm.nih.gov/18597078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

1 reference

https://pubmed.ncbi.nlm.nih.gov/18597078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dopamine partial agonists: a new class of antipsychotic

1 reference

https://pubmed.ncbi.nlm.nih.gov/18597078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls

1 reference

https://pubmed.ncbi.nlm.nih.gov/18597078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship of visceral adipose tissue and glucose disposal is independent of sex in black NIDDM subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/18597078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of olanzapine on body composition and energy expenditure in adults with first-episode psychosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18597078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Medical risk in patients with bipolar disorder and schizophrenia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18597078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prevalence of acute extrapyramidal signs and symptoms in patients treated with clozapine, risperidone, and conventional antipsychotics.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18597078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18597078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Consensus development conference on antipsychotic drugs and obesity and diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/18597078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin resistance: trigger or concomitant factor in the metabolic syndrome.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18597078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18597078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolic issues and cardiovascular disease in patients with psychiatric disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/18597078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/18597078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

From the Cover: Antipsychotic drug-induced weight gain mediated by histamine H1 receptor-linked activation of hypothalamic AMP-kinase

1 reference

https://pubmed.ncbi.nlm.nih.gov/18597078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Novel antipsychotics activate recombinant human and native rat serotonin 5-HT1A receptors: affinity, efficacy and potential implications for treatment of schizophrenia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18597078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18597078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Health behaviors and health status of older women with schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18597078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Switching antipsychotics as a treatment strategy for antipsychotic-induced weight gain and dyslipidemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18597078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extrapyramidal symptoms with atypical antipsychotics : incidence, prevention and management

1 reference

https://pubmed.ncbi.nlm.nih.gov/18597078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Obesity and cardiovascular disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18597078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release

1 reference

https://pubmed.ncbi.nlm.nih.gov/18597078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review

1 reference

https://pubmed.ncbi.nlm.nih.gov/18597078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of antipsychotic therapy on serum lipids: a comprehensive review.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18597078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antipsychotic-induced weight gain: a review of the literature

1 reference

https://pubmed.ncbi.nlm.nih.gov/18597078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diet, smoking and cardiovascular risk in people with schizophrenia: descriptive study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18597078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differences in prolactin elevation and related symptoms of atypical antipsychotics in schizophrenic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18597078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative efficacy of antipsychotics in the treatment of schizophrenia: a critical assessment

1 reference

https://pubmed.ncbi.nlm.nih.gov/18597078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18597078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management

1 reference

https://pubmed.ncbi.nlm.nih.gov/18597078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atypical antipsychotics and diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/18597078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/18597078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanism of action of aripiprazole predicts clinical efficacy and a favourable side-effect profile

1 reference

https://pubmed.ncbi.nlm.nih.gov/18597078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antipsychotic treatment and extrapyramidal symptoms amongst schizophrenic inpatients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18597078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Schizophrenia and increased risks of cardiovascular disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18597078

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00213-008-1207-7

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34791688&oldid=2197043515"